13
Dec-2018
Dec-2018
Mariner Endosurgery Wins FDA Clearance for Groundbreaking Augmented Surgical System LaparoGuard
New navigation system brings surgeons unprecedented 3D spatial awareness during minimally invasive abdominal procedures
Washington, DC, Dec. 13, 2018 (GLOBE NEWSWIRE) — Following months of review, the US Food and Drug Administration cleared Mariner Endosurgery’s LaparoGuard Augmented Surgical Navigation system for use in US operating rooms. Hospitals and surgical facilities will now be able to incorporate this game-changing surgical navigation system from Mariner, the innovative Canadian medical device company leading commercialization of advanced surgical visualization and laparoscopic instrumentation.
Original Article